New plant construction in the pharmaceutical industry frequently exceeds the allocated budget and runs over the expected time, contributing to the industry’s challenge to increase drug output over the past decade. Consulting firm Turner & Townsend estimates that some 70% of pharma construction projects miss their original budget by about 15%. Though the pandemic’s impact on…